NEW YORK – The GenomeWeb Index rose nearly 7 percent in December, ending 2020 on a high note and continuing the positive trend it exhibited in September, October, and November.
The index outperformed the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, which rose 3 percent, nearly 6 percent, and 4 percent, respectively, in December. Individual stock performances in the GenomeWeb Index were largely positive last month, as 28 of the 37 stocks saw gains and only nine saw losses.